Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
Showing the 10 most recent actions.
| Overweight |
| $144 |
| Oct 16 |
| BIIBBiogen Inc. | JP Morgan | Upgraded from Neutral | Overweight | $210 $300 | Oct 12 |
| VFCV.F. Corporation | JP Morgan | Upgraded from Underweight | Neutral | $18 | Oct 9 |
| BBDBanco Bradesco S.A. | JP Morgan | Upgraded from Neutral | Overweight | — | Oct 6 |
| RXORXO, Inc. | JP Morgan | Upgraded from Underweight | Neutral | $22 $30 | Oct 6 |
| CTVACorteva, Inc. | JP Morgan | Upgraded from Neutral | Overweight | $83 $19 | Oct 6 |
| PTCPTC Inc. | JP Morgan | Upgraded from Underweight | Neutral | $145 $205 | Oct 5 |
| VIRTVirtu Financial, Inc. | JP Morgan | Upgraded from Neutral | Overweight | $84 | Oct 5 |